A nanounit strategy reverses immune suppression of exosomal PD-L1 and is associated with enhanced ferroptosis

PD-L1 is frequently expressed on the surface of cancer cells and can be excreted from cancer cells in exosomes. Here, the authors generate a nanotherapy that combines an inhibitor of exosome production and an inducer of ferroptosis, enhancing the response to immune checkpoint blockade therapy.

Guardado en:
Detalles Bibliográficos
Autores principales: Guohao Wang, Lisi Xie, Bei Li, Wei Sang, Jie Yan, Jie Li, Hao Tian, Wenxi Li, Zhan Zhang, Ye Tian, Yunlu Dai
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Q
Acceso en línea:https://doaj.org/article/d0e25276be7f4139860cffdfc046439d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d0e25276be7f4139860cffdfc046439d
record_format dspace
spelling oai:doaj.org-article:d0e25276be7f4139860cffdfc046439d2021-12-02T17:37:13ZA nanounit strategy reverses immune suppression of exosomal PD-L1 and is associated with enhanced ferroptosis10.1038/s41467-021-25990-w2041-1723https://doaj.org/article/d0e25276be7f4139860cffdfc046439d2021-09-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-25990-whttps://doaj.org/toc/2041-1723PD-L1 is frequently expressed on the surface of cancer cells and can be excreted from cancer cells in exosomes. Here, the authors generate a nanotherapy that combines an inhibitor of exosome production and an inducer of ferroptosis, enhancing the response to immune checkpoint blockade therapy.Guohao WangLisi XieBei LiWei SangJie YanJie LiHao TianWenxi LiZhan ZhangYe TianYunlu DaiNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-12 (2021)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Guohao Wang
Lisi Xie
Bei Li
Wei Sang
Jie Yan
Jie Li
Hao Tian
Wenxi Li
Zhan Zhang
Ye Tian
Yunlu Dai
A nanounit strategy reverses immune suppression of exosomal PD-L1 and is associated with enhanced ferroptosis
description PD-L1 is frequently expressed on the surface of cancer cells and can be excreted from cancer cells in exosomes. Here, the authors generate a nanotherapy that combines an inhibitor of exosome production and an inducer of ferroptosis, enhancing the response to immune checkpoint blockade therapy.
format article
author Guohao Wang
Lisi Xie
Bei Li
Wei Sang
Jie Yan
Jie Li
Hao Tian
Wenxi Li
Zhan Zhang
Ye Tian
Yunlu Dai
author_facet Guohao Wang
Lisi Xie
Bei Li
Wei Sang
Jie Yan
Jie Li
Hao Tian
Wenxi Li
Zhan Zhang
Ye Tian
Yunlu Dai
author_sort Guohao Wang
title A nanounit strategy reverses immune suppression of exosomal PD-L1 and is associated with enhanced ferroptosis
title_short A nanounit strategy reverses immune suppression of exosomal PD-L1 and is associated with enhanced ferroptosis
title_full A nanounit strategy reverses immune suppression of exosomal PD-L1 and is associated with enhanced ferroptosis
title_fullStr A nanounit strategy reverses immune suppression of exosomal PD-L1 and is associated with enhanced ferroptosis
title_full_unstemmed A nanounit strategy reverses immune suppression of exosomal PD-L1 and is associated with enhanced ferroptosis
title_sort nanounit strategy reverses immune suppression of exosomal pd-l1 and is associated with enhanced ferroptosis
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/d0e25276be7f4139860cffdfc046439d
work_keys_str_mv AT guohaowang ananounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis
AT lisixie ananounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis
AT beili ananounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis
AT weisang ananounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis
AT jieyan ananounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis
AT jieli ananounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis
AT haotian ananounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis
AT wenxili ananounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis
AT zhanzhang ananounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis
AT yetian ananounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis
AT yunludai ananounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis
AT guohaowang nanounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis
AT lisixie nanounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis
AT beili nanounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis
AT weisang nanounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis
AT jieyan nanounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis
AT jieli nanounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis
AT haotian nanounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis
AT wenxili nanounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis
AT zhanzhang nanounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis
AT yetian nanounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis
AT yunludai nanounitstrategyreversesimmunesuppressionofexosomalpdl1andisassociatedwithenhancedferroptosis
_version_ 1718379910415777792